2019
DOI: 10.1177/1066896918824406
|View full text |Cite
|
Sign up to set email alerts
|

Myxoid Myofibroblastoma of the Breast With Atypical Cells

Abstract: The differential diagnosis of myxoid lesions in the breast is broad and includes both benign and malignant entities. Assessment is particularly challenging on core biopsy specimens. Myofibroblastoma, initially thought to be more common in the adult male breast, is being recognized with increasing frequency in the female breast. The wider anatomic distribution of mammary-type myofibroblastoma has also become known, and many new morphological variants have been described. Though focal myxoid stroma may be noted … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 17 publications
0
4
0
Order By: Relevance
“…Extramammary myofibroblastoma was first described in 2001 by McMenamin and Fletcher [ 9 ]. Although initially described and thought to be more prevalent in males, MFB affects females with a similar incidence, probably due to increased mammographic screening [ 1 , 10 , 11 ]. Tumors may be detected earlier in women due to routine mammary screening, whereas in men MFB usually presents as a painless palpable mass [ 1 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Extramammary myofibroblastoma was first described in 2001 by McMenamin and Fletcher [ 9 ]. Although initially described and thought to be more prevalent in males, MFB affects females with a similar incidence, probably due to increased mammographic screening [ 1 , 10 , 11 ]. Tumors may be detected earlier in women due to routine mammary screening, whereas in men MFB usually presents as a painless palpable mass [ 1 ].…”
Section: Discussionmentioning
confidence: 99%
“…In one case, a transgender patient developed an estrogen receptor positive MFB after receiving estrogen therapy for 13 months [ 17 ]. MFB also may be misdiagnosed as other benign or malignant breast diseases [ 1 ], particularly because clinical and radiological evidence may be suggestive of fibroadenoma [ 10 , 11 ]. Clinical presentation is characterized by a solid, solitary, slow-growing, mobile, well-circumscribed, and painless palpable mass that is firm to solid [ 3 , 10 , 13 , 18 ].…”
Section: Discussionmentioning
confidence: 99%
“…Of particular interest to practitioners of breast pathology, mammary-type myofibroblastomas are benign mesenchymal neoplasms comprised of sheets of myofibroblasts, and these tumors are often immunoreactive with desmin [11, 12]. Occasional examples of myofibroblastoma have also been reported to have myxoid features and cellular pleomorphism, as can be seen in some examples of AFH [13]. Importantly, myofibroblastomas lack a lymphoid cuff and often contain intrinsic islands of adipose tissue.…”
Section: Discussionmentioning
confidence: 99%
“…Another variants are leiomyomatous MFB, in which cells with smooth muscle cell differentiation with cigar-shaped nuclei (myoid) are present and H-caldesmon staining can be positive [27,28]; and myxoid MFB, in which there are diffuse myxoid changes [14,29,30]. This latter goes in differential diagnosis with other myxoid neoplasms, such as like low grade fibromxyoid sarcoma [31].…”
Section: Pathological Findingsmentioning
confidence: 99%